FDA denies bids to market CBD products as dietary supplements (NASDAQ:TLRY)

FDA Headquarters - White Oak Campus


The U.S. Food and Drug Administration (FDA) announced Thursday that it denied three petitions seeking the agency’s intervention to allow the marketing of CBD products as dietary supplements.

Cannabis plants contain multiple cannabinoid chemicals, including cannabidiol or CBD, a non-psychoactive

Source link

5 Trading strategies to make money

Looking to boost your trading profits?

Get you copy of our FREE Ebook Now !!!